The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
BCS class IV drugs: Highly notorious candidates for formulation development
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chaurasiya, A., Singh, A. K., Jain, G. K., Warsi, M. H., Sublet, E., Ahmad, F. J., Borchard, G., & Khar, R. K. (2012) · Journal of Microencapsulation · doi:10.3109/02652048.2012.668959 · Cited by 27
RetractedLipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Response Surface Methodology: Process and Product Optimization Using Designed Experiments
Gunst, R. F., Myers, R. H., & Montgomery, D. C. (1996) · Technometrics · doi:10.2307/1270613 · Cited by 9,530
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.019 · Cited by 3,700
Response Surface Methodology: Process and Product Optimization Using Designed Experiments
Gunst, R. F. (1996) · Technometrics · doi:10.1080/00401706.1996.10484509 · Cited by 3,255
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Cao, S.-W., & Zhu, Y.-J. (2010) · Nanoscale Research Letters · doi:10.1007/s11671-010-9742-7 · Cited by 2,357
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
(2006) · Surgery · doi:10.1016/s0039-6060(06)00616-7 · Cited by 1,642
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Lindenberg, M., Kopp, S., & Dressman, J. B. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.001 · Cited by 864
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
Quality by design for biopharmaceuticals
Rathore, A. S., & Winkle, H. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-26 · Cited by 830
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Shegokar, R., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.044 · Cited by 740
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
Manufacture and use of nanomaterials: current status in the UK and global trends
Aitken, R. J., Chaudhry, M. Q., Boxall, A. B. A., & Hull, M. (2006) · Occupational Medicine · doi:10.1093/occmed/kql051 · Cited by 638
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
Anton, N., & Vandamme, T. F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0309-1 · Cited by 621
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Nanomedicines: addressing the scientific and regulatory gap
Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. (., Tamarkin, L., & Desai, N. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 546
Quality by Design in Biopharmaceuticals
Yang, H. (2016) · doi:10.1201/9781315371726-7 · Cited by 543
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Regulatory aspects on nanomedicines
Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., Silva, L. C., Florindo, H. F., & Gaspar, R. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.023 · Cited by 417
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
Dong, Y., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.021 · Cited by 395
Carrier-Mediated Intestinal Transport of Drugs
Tsuji, A., & Tamai, I. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086003070 · Cited by 392
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Préat, V., Langer, R., & Anderson, D. G. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 390
Polymeric micelles for oral drug delivery
Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., & Leroux, J.-C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.007 · Cited by 389
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation
Jaafar-Maalej, C., Diab, R., Andrieu, V., Elaissari, A., & Fessi, H. (2010) · Journal of Liposome Research · doi:10.3109/08982100903347923 · Cited by 365
Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M., & Hageman, M. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10511 · Cited by 361
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Rousselle, C., Clair, P., Lefauconnier, J.-M., Kaczorek, M., Scherrmann, J.-M., & Temsamani, J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26466-x · Cited by 357
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Liu, Y., Li, K., Pan, J., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.036 · Cited by 342
Yu, L. X., Lipka, E., Crison, J. R., & Amidon, G. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00009-9 · Cited by 335
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Fate of polymeric nanocarriers for oral drug delivery
Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320
Bioavailability and its assessment
TOUTAIN, P. L., & BOUSQUET‐MÉLOU, A. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00604.x · Cited by 318
Nii, T., & Ishii, F. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.04.029 · Cited by 311
des Rieux, A., Fievez, V., Théate, I., Mast, J., Préat, V., & Schneider, Y.-J. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.12.006 · Cited by 310
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Feng, S.-S., Mei, L., Anitha, P., Gan, C. W., & Zhou, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.045 · Cited by 306
Lipid-Based Drug Delivery Systems
Shrestha, H., Bala, R., & Arora, S. (2014) · Journal of Pharmaceutics · doi:10.1155/2014/801820 · Cited by 304
Yin, Y.-M., Cui, F.-D., Mu, C.-F., Choi, M.-K., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.015 · Cited by 304
Nerurkar, M. M., Burton, P. S., & Borchardt, R. T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016033702220 · Cited by 287
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., Chen, C., Thompson, K., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275
Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.010 · Cited by 265
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
Aji Alex, M. R., Chacko, A. J., Jose, S., & Souto, E. B. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.10.002 · Cited by 258
Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery
Pawar, V. K., Singh, Y., Meher, J. G., Gupta, S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.030 · Cited by 250
Oral formulation strategies to improve solubility of poorly water-soluble drugs
Singh, A., Worku, Z. A., & Van den Mooter, G. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.606808 · Cited by 239
Sinha, S., Ali, M., Baboota, S., Ahuja, A., Kumar, A., & Ali, J. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9404-1 · Cited by 235
FAHMY, R., & KASSEM, M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.02.017 · Cited by 225
Entropy-induced dispersion of bulk liquids
Reiss, H. R. (1975) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(75)90035-1 · Cited by 220
A folate receptor-targeted liposomal formulation for paclitaxel
Wu, J., Liu, Q., & Lee, R. J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.027 · Cited by 212
Beloqui, A., Solins, M. N., Gascn, A. R., del Pozo-Rodrguez, A., des Rieux, A., & Prat, V. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.021 · Cited by 208
Solid-state characterization of nifedipine solid dispersions
Vippagunta, S. R., Maul, K. A., Tallavajhala, S., & Grant, D. J. W. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00019-4 · Cited by 206
Nanotechnology applications for improved delivery of antiretroviral drugs to the brain
Wong, H. L., Chattopadhyay, N., Wu, X. Y., & Bendayan, R. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.020 · Cited by 206
Italia, J. L., Bhatt, D. K., Bhardwaj, V., Tikoo, K., & Kumar, M. N. V. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.004 · Cited by 203
van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A., Borst, P., Nooijen, W., & Beijnen, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.530 · Cited by 202
Dabholkar, R. D., Sawant, R. M., Mongayt, D. A., Devarajan, P. V., & Torchilin, V. P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.018 · Cited by 200
Shao, K., Huang, R., Li, J., Han, L., Ye, L., Lou, J., & Jiang, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.018 · Cited by 191
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles
Galindo-Rodríguez, S. A., Puel, F., Briançon, S., Allémann, E., Doelker, E., & Fessi, H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.013 · Cited by 183
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
Chen, M.-L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.010 · Cited by 182
What determines drug solubility in lipid vehicles: Is it predictable?
Rane, S. S., & Anderson, B. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.015 · Cited by 176
Design and scale‐up of chemical reactors for nanoparticle precipitation
Marchisio, D. L., Rivautella, L., & Barresi, A. A. (2006) · AIChE Journal · doi:10.1002/aic.10786 · Cited by 175
Yang, S., Gursoy, R. N., Lambert, G., & Benita, S. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016238.44452.f1 · Cited by 169
Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
Liu, Y., Huang, L., & Liu, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100012s · Cited by 168
Diverse approaches for the enhancement of oral drug bioavailability
Fasinu, P., Pillay, V., Ndesendo, V. M. K., du Toit, L. C., & Choonara, Y. E. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.750 · Cited by 166
Sharma, P., & Garg, S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.019 · Cited by 165
Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., & Yamamoto, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20017 · Cited by 165
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs
Gunaseelan, S., Gunaseelan, K., Deshmukh, M., Zhang, X., & Sinko, P. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.021 · Cited by 164
Seo, Y. G., Kim, D. H., Ramasamy, T., Kim, J. H., Marasini, N., Oh, Y.-K., Kim, D.-W., Kim, J. K., Yong, C. S., Kim, J. O., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.034 · Cited by 163
Vetten, M. A., Yah, C. S., Singh, T., & Gulumian, M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.03.017 · Cited by 163
Van de Ven, H., Paulussen, C., Feijens, P. B., Matheeussen, A., Rombaut, P., Kayaert, P., Van den Mooter, G., Weyenberg, W., Cos, P., Maes, L., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.037 · Cited by 162
Novel Furosemide Cocrystals and Selection of High Solubility Drug Forms
Goud, N. R., Gangavaram, S., Suresh, K., Pal, S., Manjunatha, S. G., Nambiar, S., & Nangia, A. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22805 · Cited by 162
Enhancement of dissolution rate of piroxicam using liquisolid compacts
Javadzadeh, Y., Siahi-Shadbad, M. R., Barzegar-Jalali, M., & Nokhodchi, A. (2005) · Il Farmaco · doi:10.1016/j.farmac.2004.09.005 · Cited by 161
Targeted Cancer Therapy With Novel High Drug-Loading Nanocrystals
Liu, F., Park, J.-Y., Zhang, Y., Conwell, C., Liu, Y., Bathula, S. R., & Huang, L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22112 · Cited by 159
Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M. A., & Irache, J. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.012 · Cited by 156
Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier
Teow, H. M., Zhou, Z., Najlah, M., Yusof, S. R., Abbott, N. J., & D’Emanuele, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.024 · Cited by 155
Hydrotropic Solubilization of Poorly Water-Soluble Drugs
Kim, J. Y., Kim, S., Papp, M., Park, K., & Pinal, R. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22241 · Cited by 155
Italia, J. L., Yahya, M. M., Singh, D., & Kumar, M. N. V. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9841-2 · Cited by 149
Preparation and antitumor study of camptothecin nanocrystals
Zhang, H., Hollis, C. P., Zhang, Q., & Li, T. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.075 · Cited by 148
Modulation of oral bioavailability of anticancer drugs: from mouse to man
Schellens, J. H. M., Malingré, M. M., Kruijtzer, C. M. F., Bardelmeijer, H. A., van Tellingen, O., Schinkel, A. H., & Beijnen, J. H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00153-6 · Cited by 147
Uptake of drugs into the intestinal lymphatics after oral administration
Porter, C. J. H., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00492-9 · Cited by 135
Gelatin Coated Hybrid Lipid Nanoparticles for Oral Delivery of Amphotericin B
Jain, S., Valvi, P. U., Swarnakar, N. K., & Thanki, K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300320d · Cited by 134
Devarakonda, B., Otto, D. P., Judefeind, A., HILL, R., & DeVilliers, M. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.039 · Cited by 134
Woo, J. S., Lee, C. H., Shim, C. K., & Hwang, S. (2003) · Pharmaceutical Research · doi:10.1023/a:1022286422439 · Cited by 133
Amphotericin B topical microemulsion: Formulation, characterization and evaluation
Butani, D., Yewale, C. R., & Misra, A. R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.01.014 · Cited by 131
Sokol, R. J., Butler–Simon, N., Conner, C. L., Heubi, J. E., SINATRA, F. R., Suchy, F. J., Heyman, M. B., Perrault, J. F., Rothbaum, R., Levy, J. F., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90652-s · Cited by 130
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.024 · Cited by 128
Zabaleta, V., Ponchel, G., Salman, H. H., Agüeros, M., Vauthier, C., & Irache, J. M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.001 · Cited by 123
The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers*
Chang, T. T., Benet, L. Z., & Hébert, M. F. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80007-5 · Cited by 122
Sun, D., Yu, L. X., Hussain, M. A., Wall, D. A., Smith, R. L., & Amidon, G. L. (2004) · PubMed · Cited by 119
Nahar, M., & Jain, N. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9973-4 · Cited by 117
Bolger, M. B., Haworth, I. S., Yeung, A. K., Ann, D. K., von Grafenstein, H., Hamm‐Alvarez, S. F., Okamoto, C. T., Kim, K.-J., Basu, S. K., Wu, S. K., et al. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980090u · Cited by 108
Singh, R., Kesharwani, P., Mehra, N. K., Singh, S. K., Banerjee, S., & Jain, N. K. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1019355 · Cited by 106
The gastrointestinal stability of lipid nanocapsules
Roger, E., Lagarce, F., & Benoît, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.069 · Cited by 105
Jain, K., Verma, A., Mishra, P. R., & Jain, N. K. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.11.008 · Cited by 103
Wang, L., Liu, Z., Liu, D., Liu, C., Zhang, J., & Zhang, N. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.023 · Cited by 97
Wang, C., Ho, P. C., & Lim, L. Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.023 · Cited by 96
Kaukonen, A. M., Laitinen, L., Salonen, J., Tuura, J., Heikkilä, T., Limnell, T., Hirvonen, J. J., & Lehto, V. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.021 · Cited by 94
Beloqui, A., Solinís, M. Á., Rieux, A. D., Véronique Préat, A., & Rodríguez‐Gascón, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.027 · Cited by 93
An Investigation of Physicochemical Properties of Piroxicam Liquisolid Compacts
Javadzadeh, Y., Siahi, M. R., Asnaashari, S., & Nokhodchi, A. (2007) · Pharmaceutical Development and Technology · doi:10.1080/10837450701247574 · Cited by 89
Self-assembled nanoparticles of poly(lactide)–Vitamin E TPGS copolymers for oral chemotherapy
ZHANG, Z., & FENG, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.013 · Cited by 79
Karaküçük, A., Çelebi, N., & Teksin, Z. Ş. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.010 · Cited by 79
Taub, M. E., Kristensen, L. L., & Frøkjær, S. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00015-5 · Cited by 77
Poly(lactic acid)‐based nanocomposites
Basu, A., Nazarkovsky, M., Ghadi, R., Khan, W., & Domb, A. J. (2016) · Polymers for Advanced Technologies · doi:10.1002/pat.3985 · Cited by 77
Self-citationMoes, J. J., Koolen, S. L. W., Huitema, A. D. R., Schellens, J. H. M., Beijnen, J. H., & Nuijen, B. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.016 · Cited by 76
Theoretical Predictions of Drug Absorption in Drug Discovery and Development
Stenberg, P., m, C. A. S. B., Luthman, K., & Artursson, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00005 · Cited by 75
Ravi, P. R., Vats, R., Dalal, V., Gadekar, N., & Aditya, N. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.850710 · Cited by 73
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
Chen, H., Zheng, Y., Tian, G., Tian, Y., Zeng, X., Liu, G., Liu, K., Li, L., Li, Z., Mei, L., et al. (2010) · Nanoscale Research Letters · doi:10.1007/s11671-010-9741-8 · Cited by 72
Tuning solubility and stability of hydrochlorothiazide co-crystals
Sanphui, P., & Rajput, L. (2013) · Acta Crystallographica Section B Structural Science Crystal Engineering and Materials · doi:10.1107/s2052520613026917 · Cited by 69
Patel, K. R., Patil, A., Mehta, M., Gota, V., & Vavia, P. R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.06.031 · Cited by 65
Puligujja, P., Balkundi, S. S., Kendrick, L. M., Baldridge, H. M., Hilaire, J. R., Bade, A. N., Dash, P. K., Zhang, G., Poluektova, L. Y., Gorantla, S., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.11.012 · Cited by 64
Garg, B., Katare, O. P., Beg, S., Lohan, S., & Singh, B. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.02.012 · Cited by 62
Ravi, P. R., Vats, R., Balija, J., Adapa, S. P. N., & Aditya, N. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.099 · Cited by 58
Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitor
Agarwal, S., Boddu, S. H. S., Jain, R., Samanta, S., Pal, D., & Mitra, A. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.031 · Cited by 56
Lemke, A., Kiderlen, A. F., Petri, B., & Kayser, O. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.004 · Cited by 55
Rice, A., Michaelis, M. L., Georg, G. I., Liu, Y., Turunen, B. J., & Audus, K. L. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:339 · Cited by 49
Risovic, V., Boyd, M. C., Choo, E., & Wasan, K. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3339-3342.2003 · Cited by 48
Potential Mechanisms by Which Peceol® Increases the Gastrointestinal Absorption of Amphotericin B
Risovic, V., Sachs‐Barrable, K., Boyd, M. C., & Wasan, K. M. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120039793 · Cited by 46
Reddy, L. H., & Bazile, D. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.012 · Cited by 41
Zhang, Y., Li, X., Zhou, Y., Fan, Y., Wang, X., Huang, Y., & Liu, Y. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100033k · Cited by 38
Qi, J., Wu, W., Wang, K., Weng, T., Tian, Z., Lü, Y., Hu, K., & Yin, Z. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72560 · Cited by 36
Boudreaux, J. P., Hayes, D. H., Mizrahi, S. S., Maggiore, P., Blazek, J., & Dick, D. (1993) · PubMed · Cited by 36
Enhanced Delivery of Lopinavir to the Cns Using Compritol®-Based Solid Lipid Nanoparticles
Raynold, A. A. M., Paul, W., Chacko, A. J., & Sharma, C. P. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.96 · Cited by 34
Negi, J. S., Chattopadhyay, P., Sharma, A. K., & Ram, V. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0154-y · Cited by 33
Ibrahim, F., Gershkovich, P., Sivak, O., Wasan, E. K., & Wasan, K. M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.02.008 · Cited by 30
Chitosan Coated Furosemide Liposomes for Improved Bioavailability
Vural, İ., Sarısözen, C., & Olmez, S. S. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1294 · Cited by 27
Stevens, D. M., Gilmore, K. A., & Harth, E. M. (2014) · Polymer Chemistry · doi:10.1039/c4py00207e · Cited by 19
Augmented Inhibition of CYP3A4 in Human Primary Hepatocytes by Ritonavir Solid Drug Nanoparticles
Martin, P., Giardiello, M., McDonald, T. O., Smith, D., Siccardi, M., Rannard, S. P., & Owen, A. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00204 · Cited by 16
Bhardwaj, V., Plumb, J. A., Cassidy, J., & Kumar, M. N. V. R. (2010) · Cancer Nanotechnology · doi:10.1007/s12645-010-0004-2 · Cited by 12
Sambaraj, S., Ammula, D., & Nagabandi, V. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.055 · Cited by 10
Cited by
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Yang, C., Wu, T., Qi, Y., & Zhang, Z. (2018) · Theranostics · doi:10.7150/thno.22711 · Cited by 402
Lee, M.-K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030264 · Cited by 335
Li, Z., Zhang, Y., & Feng, N. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1575806 · Cited by 321
Zhang, X., Xing, H., Zhao, Y., & Ma, Z. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030074 · Cited by 285
Metadata
- Authors
- Ghadi, R., & Dand, N.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 248
- Pages
- 71-95
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2578110183
- Cited by
- 361
- References
- 145
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.